尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Schachle Joseph K. Director active across 2 companies, notably Opus Genetics, Inc.. Aggregated, 6 disclosures have been recorded. Breakdown: 1 buy · 3 sells. Total volume traded: €54k. History available since 21 March 2024. The latest transaction was filed on 23 July 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
SCHACHLE JOSEPH K is a declarant linked to Opus Genetics, Inc. and Ocuphire Pharma, Inc., where he is Chief Operating Officer. He has 4 filings in total, and in the 4 recent filings we hold, buys amount to EUR 3749 and sells to EUR 38060, between 2024-03-25 and 2026-04-27.